tamibarotene

Related by string. Tamibarotene * * *

Related by context. All words. (Click for frequent words.) 74 Tamibarotene 71 clofarabine 70 amrubicin 69 MGCD# [001] 69 Amrubicin 68 tanespimycin 67 refractory APL 67 TRISENOX 67 bafetinib 67 Nexavar ® 66 JAK inhibitor 66 rNAPc2 66 thymalfasin 66 Azedra 66 perifosine 66 pralatrexate 65 tivozanib 65 Allovectin 7 R 65 alvespimycin 65 registrational 65 forodesine 65 AP# [003] 65 Targretin 65 pomalidomide 65 incyclinide 65 alvimopan 65 AQ4N 65 TELCYTA 65 EOquin 64 diabetic neuropathic pain 64 Zerenex 64 IMGN# 64 Actimmune ® 64 relapsed refractory multiple myeloma 64 AEG# 64 Ceflatonin 64 carfilzomib 64 oncology indications 64 IMA# 64 Cloretazine ® 64 talactoferrin 64 metaglidasen 64 ofatumumab 64 Clolar ® 64 deforolimus 64 valopicitabine 64 tesetaxel 64 TREANDA 64 YONDELIS 64 #D#C# 64 Traficet EN 64 FOLOTYN 64 Troxatyl 64 Marqibo 64 vosaroxin 64 HuMax CD4 64 Tarceva TM 64 Bezielle 64 Dacogen injection 64 Orphan Drug designations 64 TEMODAL 63 Gemzar ® 63 phase IIb clinical 63 phase IIa clinical 63 confirmatory Phase III 63 oral prodrug 63 OncoVEX GM CSF 63 bendamustine 63 HER2 positive metastatic breast 63 docetaxel Taxotere R 63 Irinotecan 63 PNP inhibitor 63 relapsed multiple myeloma 63 TELINTRA 63 refractory PTCL 63 tezampanel 63 ularitide 63 radiation sensitizer 63 Cladribine Tablets 63 obatoclax 63 elotuzumab 63 TORISEL 63 regadenoson 63 Archexin 63 ADVEXIN 63 lumiliximab 63 Perifosine 63 romidepsin 63 ridaforolimus 63 trabectedin 63 LEP ETU 63 refractory chronic lymphocytic 63 Soliris TM eculizumab 63 PXD# 63 Amplimexon 63 GATTEX 63 Alzhemed TM 63 PREOS 63 PRT# 62 IMiDs 62 Icatibant 62 L BLP# 62 Stedivaze 62 dasatinib Sprycel ® 62 ambrisentan 62 ATryn R 62 HGS ETR1 62 INCB# [002] 62 SNT MC# 62 enzastaurin 62 ganetespib 62 fidaxomicin 62 ixabepilone 62 Onalta ™ 62 Clolar 62 BAY #-# 62 subcutaneous formulation 62 Cloretazine R VNP#M 62 HGS# 62 Belinostat 62 Civacir 62 erlotinib Tarceva ® 62 celgosivir 62 blinatumomab 62 PDE4 inhibitor 62 mifamurtide 62 KNS # 62 PD LID 62 Insegia 62 Panzem R NCD 62 Tarceva erlotinib 62 OvaRex ® MAb 62 Annamycin 62 Evoltra TM 62 Evoltra ® 62 fipamezole 62 Nimotuzumab 62 eltrombopag 62 PF # [001] 62 tafamidis 62 MAGE A3 ASCI 62 Panzem R 62 SYCREST 62 albinterferon alfa 2b 62 MEK inhibitors 62 Fludara 62 golimumab 62 torezolid phosphate 62 MOZOBIL 62 Allovectin 7 ® 62 ONCONASE 62 EOquin TM 62 ATryn ® 62 Orphan Drug designation 62 custirsen 62 rilonacept 62 HuLuc# 62 hematologic malignancies 61 Firazyr 61 Abraxane 61 Panzem 61 bevacizumab Avastin ® 61 sorafenib tablets 61 axitinib 61 PEG SN# 61 Phenoptin 61 interferon gamma 1b 61 OMAPRO 61 maribavir 61 omacetaxine mepesuccinate 61 refractory multiple myeloma 61 visilizumab 61 ALN TTR# 61 romiplostim 61 XL# [003] 61 Campath ® 61 ONTAK 61 Neulasta R 61 refractory Hodgkin lymphoma 61 pradefovir 61 lesinurad 61 Orphan Drug status 61 BENLYSTA 61 indolent NHL 61 ZOLINZA 61 R#/MEM # 61 cutaneous T cell 61 Ceplene 61 entinostat 61 Behcet uveitis 61 bardoxolone 61 PEG PAL 61 Triolex 61 ruxolitinib 61 HQK 61 ELACYT 61 histone deacetylase HDAC inhibitor 61 Clevudine 61 EndoTAG TM -1 61 CORT # 61 atacicept 61 Restanza 61 ospemifene 61 Raptiva ® 61 lintuzumab SGN 61 calcineurin inhibitors 61 CCX# 61 anti TNF alpha 61 anticancer agent 61 novel histone deacetylase 61 reslizumab 61 Aurexis 61 ARIKACE ™ 61 apaziquone 61 Imprime PGG 61 herpetic keratitis 61 SARMs 61 NEUMUNE 61 biologic therapy 61 RELISTOR ® 61 Rebif ® 61 luliconazole 61 orphan medicinal product 61 ALN PCS 61 Teysuno 61 fenofibric acid 61 HepeX B 61 MAXY G# 61 teduglutide 61 Onalta 61 Shigamabs ® 61 histone deacetylase inhibitor 61 ZEVALIN 61 sorafenib Nexavar 61 FRDA 61 RG# [001] 61 anti EGFR antibody 61 TBC# 61 Asentar 61 TOCOSOL Paclitaxel 61 Allovectin 7 61 eniluracil 61 PLK1 SNALP 61 IAP inhibitors 61 pegfilgrastim 61 Octreolin 61 Folotyn 61 IRESSA 61 metastatic CRC 61 panitumumab 61 HUMIRA 61 generation Hsp# inhibitor 61 Cethrin 61 veltuzumab 61 HspE7 61 satraplatin 61 opioid induced bowel dysfunction 61 B CLL 61 Amigal 61 Mipomersen 61 MAA submission 61 DAVANAT R 61 omacetaxine 60 NPSP# 60 orphan designation 60 hematological malignancies 60 docetaxel Taxotere ® 60 lubiprostone 60 CR# vcMMAE 60 Entereg R 60 trans retinoic acid ATRA 60 RhuDex ® 60 vandetanib 60 Avastin bevacizumab 60 ZYBRESTAT 60 Velcade bortezomib 60 SCH # 60 carboplatin paclitaxel 60 TRISENOX R 60 picoplatin 60 INCB# [001] 60 sunitinib malate 60 Phase III clinical 60 FavId 60 OPAXIO 60 targeted radiotherapeutic 60 gemcitabine chemotherapy 60 Onco TCS 60 pan HDAC inhibitor 60 docetaxel Taxotere 60 orBec R 60 Tyrima 60 metastatic renal cell carcinoma 60 telaprevir VX 60 Genasense 60 HRPC 60 dacarbazine 60 MGd 60 topical NSAID 60 drug ISA# 60 AZILECT ® 60 pseudobulbar affect PBA 60 temsirolimus 60 BEXXAR 60 PEG Interferon lambda 60 vorinostat 60 oral ridaforolimus 60 elacytarabine 60 Tanespimycin 60 Aplidin 60 Tekturna HCT 60 Anturol 60 regorafenib 60 HGS ETR2 60 pivotal Phase III 60 Jevtana 60 acyclovir Lauriad R 60 XL# anticancer compounds 60 EFAPROXYN 60 leading oral taxane 60 dimebon 60 lurasidone 60 CEQ# 60 IMiD 60 Pegasys ® 60 GALNS 60 Bortezomib 60 investigational compound 60 Trofex 60 Chemophase 60 AzaSite Plus 60 epothilone 60 dextromethorphan quinidine 60 methylnaltrexone bromide 60 Actemra tocilizumab 60 Genasense ® 60 multiple myeloma MM 60 CAELYX 60 ASA# 60 L MTP PE 60 NEBIDO 60 PDX pralatrexate 60 daclizumab 60 BrachySil 60 Tavocept 60 PROMACTA 60 TRANSDUR Sufentanil 60 Doxil 60 methylnaltrexone 60 investigational humanized monoclonal antibody 60 Alpharadin 60 ostarine 60 Cetrorelix 60 mCRC 60 mapatumumab 60 Mepact 60 forodesine hydrochloride 60 RoACTEMRA 60 receptor tyrosine kinase inhibitor 60 refractory CLL 60 XmAb# 60 linaclotide 60 Loramyc R 60 PHX# 60 registrational trial 60 virus HCV protease inhibitor 60 Xanafide 60 KRN# 60 mertansine 60 metastatic hormone refractory 60 oxymorphone ER 60 Fibrillex TM 60 sapacitabine 60 arsenic trioxide injection 60 ASONEP 60 Mozobil 60 TRISENOX ® 60 LHRH antagonist 60 hematological cancers 60 PROVIGIL 60 HCV protease inhibitors 60 Evoltra 60 APOPTONE 60 MabCampath 60 NUVIGIL 60 NOXAFIL 60 volociximab 60 LEVADEX ™ 60 Treanda 60 NP2 Enkephalin 60 Exherin TM 60 elagolix 60 silodosin 60 metastatic colorectal cancer 60 neratinib 60 MAXY alpha 60 arsenic trioxide ATO 60 favorable pharmacokinetic profile 59 Bicifadine 59 cutaneous T 59 NXL# 59 Carfilzomib 59 Soliris eculizumab 59 OXi# 59 MEK inhibitor 59 Fast Track designations 59 orally administered inhibitor 59 ALN TTR 59 CINTREDEKIN BESUDOTOX 59 PS# [001] 59 Zenvia ™ 59 DPP4 inhibitor 59 ThermoDox ® 59 TRAIL receptor antibodies 59 Fx #A 59 GTC recombinant human 59 novel VDA molecule 59 huN# DM1 59 Taxotere ® 59 generation purine nucleoside 59 orBec 59 Dapagliflozin 59 lapatinib Tykerb 59 REBETOL combination therapy 59 Stimuvax R 59 recurrent NSCLC 59 Onconase 59 AGGRASTAT ® 59 ZADAXIN ® 59 lymphoma CTCL 59 Vandetanib 59 sorafenib Nexavar ® 59 Proxinium TM 59 posaconazole 59 refractory gout 59 liposomal formulation 59 immunotherapeutic agent 59 Cimzia TM 59 evaluating tivozanib 59 ALN VSP 59 PI3K/Akt pathway inhibitor 59 LEUKINE 59 Myocet 59 Neulasta ® 59 nimotuzumab 59 Sym# 59 Serdaxin 59 Angiox 59 Arcalyst 59 lenalidomide Revlimid R 59 DXL# 59 CoFactor 59 Clofarabine 59 HCD# [002] 59 XIFAXAN R 59 Intravenous CP 59 Combidex 59 Plenaxis R 59 imatinib Gleevec ® 59 GW# [003] 59 BCX# 59 hypoparathyroidism 59 proteasome inhibitor 59 Mylotarg 59 betrixaban 59 Cellegesic 59 Acute Myeloid Leukemia AML 59 Cimzia ® certolizumab pegol 59 RDEA# 59 Exelixis compounds 59 selective androgen receptor modulator 59 zanolimumab 59 advanced NSCLC 59 rufinamide 59 DAVANAT ® 59 Zolinza 59 Q#IR 59 pitavastatin 59 ZADAXIN 59 MDV# 59 voreloxin 59 darapladib 59 ocular formulation 59 CCR5 antagonist 59 hormone refractory prostate cancer 59 Cimzia 59 SEBIVO 59 mTOR inhibitor 59 Aflibercept 59 amifampridine phosphate 59 arimoclomol 59 superficial bladder cancer 59 Zavesca R 59 anticancer compound 59 dalbavancin 59 trastuzumab Herceptin R 59 AeroLEF TM 59 FOLFOX chemotherapy 59 INNO 59 Evoltra R 59 monotherapy 59 Argatroban 59 Sebivo 59 T DM1 59 Urocidin 59 antibody MAb 59 Dalbavancin 59 CHOP chemotherapy 59 PROVENGE sipuleucel T 59 R sorafenib tablets 59 cilengitide 59 orally bioavailable 59 PSMA ADC 59 eculizumab 59 nonclinical studies 59 Orazol 59 ProSavin 59 Ophena TM 59 vidofludimus 59 BCR ABL inhibitor 59 PREOS R 59 HCV protease inhibitor 59 Torisel 59 CBLC# 59 Phase #b/#a clinical 59 Zavesca r 59 Bronchitol 59 Phase #b/#a 59 CD3 monoclonal antibody 59 AVASTIN 59 Vidaza 59 MYDICAR ® 59 ONCASPAR 59 xanthine oxidase inhibitor 59 OHR/AVR# 59 Phase Ib study 59 Solazed 59 febuxostat 59 UPLYSO 59 refractory metastatic colorectal cancer 59 Viprinex 59 ISIS # 59 oral proteasome inhibitor 59 belinostat 59 Solazed TM 59 ponatinib 59 GATTEX ® 59 Rescula 59 Yondelis 59 YONDELIS R 59 Phase Ib 59 polymerase inhibitor 59 Azixa 59 chronic lymphocytic leukemia CLL 59 Iluvien ® 59 Ventavis 59 ThermoDox R 59 GED aPC 59 IL# PE#QQR 59 nab paclitaxel 59 XL# XL# 59 docetaxel chemotherapy 59 Augment TM 59 erlotinib 59 relapsed MM 59 edoxaban 59 gemcitabine Gemzar 59 Xcytrin R 59 clevudine 59 IV APAP 59 RAPAFLO 59 cell lymphoma CTCL 59 Increlex ® 59 RAPTIVA 59 Phase IIIb clinical 59 Leukine 59 Ceflatonin ® 59 HuMax EGFr 59 masitinib 59 TYZEKA 59 AzaSite Xtra 59 Lenocta 59 Oracea ® 59 cannabinor 59 VPRIV 59 HepeX B TM 59 Pradefovir 59 pertuzumab 58 abatacept Orencia 58 Phase 2a 58 rhC1INH 58 Junovan TM 58 hoFH 58 Besivance 58 Corlux 58 IND submission 58 XYOTAX 58 Aviptadil 58 6R BH4 58 SAR# [004] 58 PANVAC VF 58 CIMZIA TM 58 vilazodone 58 PEG INTRON 58 Pirfenidone 58 Frova ® 58 Huntexil 58 GATTEX ™ 58 SIMPONI 58 Revimmune 58 Rhucin ® 58 oral antiviral 58 ARCOXIA 58 lomitapide 58 erlotinib Tarceva R 58 taliglucerase alfa 58 MEPACT 58 Ceflatonin R 58 investigational therapies 58 Glybera 58 cancer immunotherapies 58 BENLYSTA ® 58 oral taxane 58 BEMA Buprenorphine 58 XP# XP# 58 mRCC 58 cinacalcet HCl 58 Phase Ib clinical trials 58 Arranon 58 cariprazine 58 zileuton 58 Multiferon R 58 Erbitux cetuximab 58 Exforge 58 terlipressin 58 oral deforolimus 58 Phase 2b study 58 novel anticancer 58 mipomersen 58 TYKERB 58 Paclitaxel 58 ozarelix 58 FOLOTYN ® 58 oral anticoagulant 58 Zalbin 58 alemtuzumab Campath 58 ocrelizumab 58 Gabapentin GR 58 faropenem 58 GLPG# 58 NGX# 58 voclosporin 58 bortezomib Velcade 58 VISICOL R 58 bevacizumab Avastin 58 mitogen activated ERK kinase 58 severe hypercholesterolemia 58 VEGF Trap 58 Raptiva R 58 Valortim 58 investigational drug 58 MT# MEDI 58 Toraymyxin TM 58 Lucanix R 58 metastatic castration resistant 58 Nanobody 58 dose cohorts 58 riociguat 58 sulodexide 58 Exelixis XL# 58 Oracea TM 58 eprotirome 58 Azedra TM 58 ZEFTERA TM Zevtera TM 58 nitazoxanide 58 phase IIb trial 58 elvucitabine 58 otelixizumab 58 adecatumumab 58 thalidomide Thalomid 58 ABILIFY R 58 low dose cytarabine 58 Kepivance 58 Nexavar 58 pain palliation 58 topical antifungal 58 Vectibix 58 Vidaza R 58 APTIVUS 58 Augment Injectable 58 brentuximab vedotin 58 Androxal TM 58 Neurodex 58 rindopepimut 58 dirucotide 58 Peginterferon alfa 2b 58 initiate Phase 1b 58 Cloretazine 58 advanced metastatic prostate 58 active moiety 58 pafuramidine 58 Junovan 58 Hsp# inhibitor 58 Genz # 58 bortezomib Velcade R 58 Phase IIb trials 58 POSIDUR 58 Cinryze ™ 58 Phase 1b trial 58 VIDAZA 58 relapsing remitting multiple sclerosis 58 ATPace 58 metastatic sarcomas 58 PrevOnco ™ 58 ANYARA 58 DORIBAX 58 oral cladribine 58 paclitaxel Taxol ® 58 Pimavanserin 58 oxaliplatin 58 XL# XL# XL# XL# 58 Chronic Idiopathic Constipation 58 Erlotinib 58 HSP# inhibitor 58 Aloxi R 58 BRIM2 58 BRAF inhibitor 58 Omacetaxine 58 alkylating agent 58 sargramostim 58 cetuximab Erbitux R 58 EGFR expressing mCRC 58 metastatic melanoma 58 Zerenex ™ 58 Herceptin trastuzumab 58 Zingo TM 58 Serdaxin ® 58 BCR ABL inhibitors 58 Linjeta TM 58 oxypurinol 58 relapsed leukemia 58 oral FTY# 58 CCR9 antagonist 58 Navelbine ® 58 unresectable 58 non metastatic osteosarcoma 58 Cardio Vascu Grow 58 ATL# [002] 58 iSONEP 58 hepatitis C HCV 58 Relistor 58 vascular disrupting agent 58 urocortin 2 58 RLY# 58 Aryplase 58 opioid induced constipation 58 Tarceva 58 teriflunomide 58 perampanel 58 Golimumab 58 Hycamtin 58 IV Busulfex 58 Increlex R 58 Fodosine 58 Amitiza 58 PEGylated interferon beta 1a 58 Triapine 58 Leukine ® 58 Orphan Drug Designation 58 ERBITUX 58 evaluating REVLIMID 58 HuMax CD# 58 temozolomide 58 FROVA 58 PEP# [003] 58 MoxDuo IR 58 epratuzumab 58 Dacogen 58 Daclizumab 58 IMiDs ® 58 Excellarate 58 medullary thyroid cancer 58 UVIDEM 58 BiovaxID TM 58 Frova R 58 bazedoxifene 58 tecarfarin 58 glufosfamide 58 Rhucin R 58 refractory acute myeloid 58 Phase 2b 58 IBS C 58 cetuximab Erbitux ® 58 Noxafil 58 phase Ib 58 CANCIDAS 58 Arimoclomol 58 catheter occlusion 58 Genentech Roche 58 Proquin XR 58 IGF 1R inhibitor 58 MyVax R 58 velaglucerase alfa 58 BRAF V# mutation 58 AZILECT R 58 Plenaxis TM 58 multicenter Phase III 58 mitiglinide 58 lorvotuzumab mertansine 58 EP #R 58 Certican 58 VitiGam 58 metastatic castrate resistant 58 chemotherapy induced neutropenia 58 CIMZIA ™ 58 tipifarnib 58 Debio 58 panitumumab Vectibix 58 tezampanel NGX# 58 Pazopanib 57 Pivotal Phase III 57 Phase #/#a trial 57 CD# CEA 57 Vilazodone 57 AZX# 57 Prodarsan ® 57 Acapodene 57 ONGLYZA ™ 57 forodesine HCl 57 Ceplene/IL-2 57 SPRYCEL ® 57 systemic ALCL 57 Perforomist ™ Inhalation Solution 57 miconazole Lauriad 57 Neuradiab 57 Panzem NCD 57 Phase III 57 TH# [003] 57 Factor VIIa 57 DAVANAT 57 CB2 selective receptor agonist 57 Pivotal Phase 57 EndoTAG TM 57 Phase IIb clinical 57 infusional 5-FU/LV 57 acute promyelocytic leukemia APL 57 ISTODAX 57 rFVIIIFc 57 Oncaspar 57 taxane 57 Taxotere R 57 Vectibix panitumumab 57 R#/MEM 57 OvaRex R 57 Teflaro 57 Symadex 57 refractory indolent non 57 REMICADE infliximab 57 Keppra ® 57 Voreloxin 57 AVONEX ® 57 cystinosis patients 57 aflibercept 57 Orphan Drug Status 57 Actemra 57 aflibercept VEGF Trap 57 Prednisporin TM 57 Gleevec Glivec 57 Azilect ® 57 Triapine R 57 Targretin capsules 57 ciclesonide 57 Aptivus 57 teplizumab 57 Phase 2b trial 57 AAG geldanamycin analog 57 PRTX 57 standard chemotherapy regimen 57 adenosine injection 57 omecamtiv mecarbil 57 ZENPEP 57 VALSTAR 57 Fludara ® 57 atrial fibrillation budiodarone ATI 57 intravenous formulation 57 HGS ETR1 mapatumumab 57 Vasovist 57 Zoraxel 57 lintuzumab 57 fenofibrate 57 class mGluR5 inhibitor 57 ZK EPO 57 synthetic retinoid 57 tesmilifene 57 Phase III trials 57 prostone 57 Urocidin TM 57 sorafenib 57 CYCLOSET 57 post herpetic neuralgia PHN 57 BYDUREON 57 dipeptidyl peptidase 4 57 Preclinical studies suggest 57 Clonicel 57 dosing cohort 57 vemurafenib 57 afatinib 57 Fast Track designation 57 dexanabinol 57 CYT# potent vascular disrupting 57 seliciclib CYC# 57 recurrent GBM 57 INVANZ 57 mycophenolate mofetil 57 NSCLC 57 TKM ApoB 57 Elagolix 57 Desmoteplase 57 hereditary deficiency 57 PhosLo 57 retigabine 57 oral fludarabine 57 squalamine 57 TREDAPTIVE 57 phase IIb III 57 Cimzia ® 57 relapsing multiple sclerosis 57 doxorubicin HCl liposome injection 57 Abiraterone acetate 57 FOSRENOL 57 FOLFOX6 chemotherapy regimen 57 NEUGENE 57 decitabine 57 CORLUX 57 relapsing forms 57 Satraplatin 57 candidates bavituximab 57 Vicinium TM 57 imetelstat 57 rhThrombin 57 FOLFIRI 57 ACTEMRA 57 Xcytrin 57 OMP designation 57 pegylated interferon alfa 57 metastatic GIST 57 generation proteasome inhibitor 57 MIRCERA 57 oral calcitonin 57 Relivar 57 BCG refractory 57 Orphan Status 57 CA4P 57 granulated mesalamine 57 Pemetrexed 57 DP b# 57 active comparator 57 tocilizumab 57 Phase Ib II 57 nilotinib Tasigna ® 57 ARIKACE 57 BLA filing 57 Multaq R 57 Kuvan 57 trastuzumab DM1 T DM1 57 TLK# 57 vascular disrupting agents 57 ceftazidime 57 telomerase therapeutic 57 thetreatment 57 oral gallium 57 Zemiva TM 57 Plicera 57 IMiDs R 57 HDAC inhibitor 57 palonosetron 57 Ruconest 57 carbidopa levodopa 57 lapatinib 57 Solazed ™ 57 darinaparsin ZIO 57 pegylated interferon alpha 57 XL# XL# XL# 57 Naglazyme 57 uric acid lowering 57 anti TNF 57 VELCADE 57 pharmacodynamic properties 57 PEGylated Fab fragment 57 rheumatoid arthritis psoriatic arthritis 57 darinaparsin 57 liposomal doxorubicin 57 systemically administered 57 Nicole Onetto MD 57 CINOD 57 fluoropyrimidine 57 Dual Opioid 57 dasatinib Sprycel 57 systemic immunosuppressive drugs

Back to home page